Test Bank for Ruppel’s Manual of Pulmonary Function Testing 12th Edition, By Mottram Chapter 1 - 13 Updated

Test Bank for Ruppel’s Manual of Pulmonary
Function Testing 12th Edition, By Mottram
Chapter 1 - 13 Updated

,Chapter 1: Indications for Pulmonary Function
Testing Test Bank



MULTIPLE CHOICE

1. Who first popularized spirometry for the evaluation of pulmonary function?
a. August and Marie Krogh
b. Alvan Barach
c. John Severinghaus
d. John Hutchinson

ANS: D
Hutchinson popularized the concept of using VC to assess lung function,
and the names he gave to several other lung compartments are still used
today.

DIF: 1 REF: p. 2 OBJ: None MSC: NBRC: None

2. Which of the following are indications for performing spirometry?
1. Assess the risk of lung resection.
2. Determine the response to bronchodilator therapy.
3. Assess the severity of restrictive lung disease.
4. Quantify the extent of COPD.
a. 1 and 4
b. 2 and 3
c. 1 , 2, and 4
d. 2 , 3, and 4

ANS: C
Spirometry cannot assess severity of restriction; for that you need to
measure lung volumes ( see Box 1-2, Chapter 1).

DIF: 1 REF: p. 7 OBJ: EL-2 MSC: NBRC: None

,3. TheXZmainXZindicationXZforXZtheXZmeasurementXZofXZlungXZvolumesXZisXZtoX
ZdoXZwhichXZofXZtheXZfollowing?

a. DiagnoseX Z orX Z assessX Z theX Z severityX Z ofX Z restriction.
b. EvaluateXZ theXZ severityXZ ofXZ pulmonaryXZ hypertension.
c. DetermineXZtheXZlevelXZofXZcardiopulmonaryXZfitness.
d. AssessXZ theXZ riskX Z ofXZ abdominalX Z surgicalX Z procedures.

ANS:XZA
TheXZmostXZcommonXZreasonXZforXZmeasuringXZlungXZvolumesXZisXZtoX

ZidentifyXZrestrictiveXZlungXZdisease.XZDIF: 1 REF:

p.XZ35XZOBJ: EL-2

MSC:XZNBRC:XZNone

4. DLCOXZmeasurementsXZmayXZbeXZindicatedXZtoXZevaluateXZpulm
onaryXZinvolvementXZinXZwhichXZofXZtheXZfollowingXZsystemicXZ
diseases?
a. Asthma
b. Sarcoidosis
c. ExertionalXZhypoxemia

, Stuvia.comXZ-XZTheXZMarketplaceXZtoXZBuyXZandXZSellXZyourXZStudyXZMaterial


d. Guillain-BarréXZsyndrome

ANS:XZB
SarcoidosisXZisXZtheXZonlyXZsystemicXZdiseaseXZlistedXZthatXZ

affectsXZgasXZexchange.XZDIF:XZ1XZREF:XZp.XZ9XZ|XZp.XZ19XZ|X

Zp.XZ21XZ|XZp.XZ35XZOBJ:XZEL-2XZMSC:XZNBRC:XZNone


5. BloodXZgasXZanalysisXZisXZusedXZwithXZpatientsXZwithXZC
OPDXZtoXZdoXZwhichXZofXZtheXZfollowing?
a. MonitorXZairwayXZresponsiveness.
b. DetermineXZlevelXZofXZcardiopulmonaryXZfitness.
c. DetectXZ pulmonaryX Z hypertension.
d. AssessXZneedXZforXZsupplementaryXZO2.

ANS:XZD
BloodXZgasXZanalysisXZisXZmostXZcommonlyXZusedXZtoXZdetermineXZtheXZneed
XZforXZsupplemental XZoxygenXZandXZtoXZmanageXZpatientsXZwhoXZrequireXZve
ntilatoryXZsupport.

DIF: 2 REF:X Z X Z p.XZ15X Z OBJ:
EL-1XZMSC:XZNBRC:XZCPFTXZ2A-2

6. WhichXZofXZtheXZfollowingXZcauseXZemphysema?
1. 1-XZAntitrypsinXZdeficiency
2. ExposureXZ toXZ environmentalX Z pollutants
3. RadiationXZ therapy
4. CigaretteXZsmoking
a. 1X Z andX Z 2
b. 3X Z andX Z 4
c. 1XZ,XZ2,XZandX Z 4
d. 2XZ,XZ3,XZandX Z 4

ANS:XZC
EmphysemaX Z isX Z causedX Z primarilyX Z byX Z cigaretteX Z smoking.X Z SomeX Z e
mphysemaXZisXZcausedXZbyXZtheXZabsenceXZofXZaXZprotectiveXZenzyme.XZChr
onicXZexposureXZtoXZenvironmentalXZpollutantsXZcanXZalsoXZcontributeXZtoXZ
theXZdevelopmentXZofXZemphysema.

DIF: 1 REF:XZXZ p.XZ11X Z OBJ: EL-3XZ|XZAL-2X Z MSC:XZNBRC:XZNone

7. AnXZadultXZpatientXZcomplainsXZofXZchestXZtightnessXZandXZcoughXZwhene
verXZheXZjogsXZinXZcoldXZweather.XZTheseXZsymptomsXZareXZconsistentXZw
ithXZwhichXZofXZtheXZfollowing?
a. CysticXZ fibrosis
b. Asthma
c. PulmonaryX Z hypertension
d. IdiopathicXZ pulmonaryXZ fibrosis

|